Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Poseida Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +14 vs. Q4 2022
- Shares held
- 44.1M
- +1.08M (+2.5%) vs. Q4 2022
- Total value
- $136.0M
- −$91.6M (−40.3%) vs. Q4 2022
- New holders
- 28
- 35 more added
- Sold out
- 14
- 22 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $308.0K |
| Q4 2024 | 116 | $519.2M |
| Q3 2024 | 96 | $153.4M |
| Q2 2024 | 93 | $154.9M |
| Q1 2024 | 91 | $168.6M |
| Q4 2023 | 91 | $152.4M |
| Q3 2023 | 86 | $107.6M |
| Q2 2023 | 94 | $78.4M |
| Q1 2023 | 102 | $136.0M |
| Q4 2022 | 89 | $227.6M |
| Q3 2022 | 68 | $141.8M |
| Q2 2022 | 56 | $58.1M |
| Q1 2022 | 64 | $108.4M |
| Q4 2021 | 66 | $178.4M |
| Q3 2021 | 65 | $190.7M |
| Q2 2021 | 71 | $279.3M |
| Q1 2021 | 62 | $276.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Poseida Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pentwater Capital Management LP | 5,975,000 | $18.4M | 0.31% | 00.0% | Unchanged |
| FMR LLC | 12,979,080 | $40.0M | 0.00% | +86,673+0.7% | Added |
| Bank of Montreal | 0 | $0 | 0.00% | −399,472−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −290,349−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −218,305−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −64,371−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −18,385−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −17,319−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −15,975−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −10,827−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −7,146−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,986−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −325−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| HealthInvest Partners AB | – | – | – | – | Not filed |